Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 4
2010 2
2011 1
2012 2
2016 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Metformin for the treatment of the polycystic ovary syndrome.
Nestler JE. Nestler JE. N Engl J Med. 2008 Jan 3;358(1):47-54. doi: 10.1056/NEJMct0707092. N Engl J Med. 2008. PMID: 18172174 Review. No abstract available.
Cardiometabolic aspects of the polycystic ovary syndrome.
Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, Lehnert H. Randeva HS, et al. Endocr Rev. 2012 Oct;33(5):812-41. doi: 10.1210/er.2012-1003. Epub 2012 Jul 24. Endocr Rev. 2012. PMID: 22829562 Free PMC article. Review.
Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome.
Gupta A, Jakubowicz D, Nestler JE. Gupta A, et al. Metab Syndr Relat Disord. 2016 Oct;14(8):391-396. doi: 10.1089/met.2016.0009. Epub 2016 Mar 30. Metab Syndr Relat Disord. 2016. PMID: 27028341 Free PMC article. Clinical Trial.
Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome.
Wickham EP 3rd, Cheang KI, Clore JN, Baillargeon JP, Nestler JE. Wickham EP 3rd, et al. Metabolism. 2011 Mar;60(3):366-72. doi: 10.1016/j.metabol.2010.02.019. Epub 2010 Mar 31. Metabolism. 2011. PMID: 20359725 Free PMC article.
Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.
Baillargeon JP, Nestler JE, Ostlund RE, Apridonidze T, Diamanti-Kandarakis E. Baillargeon JP, et al. Hum Reprod. 2008 Jun;23(6):1439-46. doi: 10.1093/humrep/den097. Epub 2008 Mar 29. Hum Reprod. 2008. PMID: 18375940 Free PMC article.
Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.
Cheang KI, Baillargeon JP, Essah PA, Ostlund RE Jr, Apridonize T, Islam L, Nestler JE. Cheang KI, et al. Metabolism. 2008 Oct;57(10):1390-7. doi: 10.1016/j.metabol.2008.05.008. Metabolism. 2008. PMID: 18803944 Free PMC article. Clinical Trial.
A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.
Nestler JE, Reilly ER, Cheang KI, Bachmann LM, Downs RW Jr. Nestler JE, et al. Trans Am Clin Climatol Assoc. 2012;123:209-19; discussion 219-20. Trans Am Clin Climatol Assoc. 2012. PMID: 23303986 Free PMC article. Clinical Trial.
Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.
Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE. Baillargeon JP, et al. Metab Syndr Relat Disord. 2010 Apr;8(2):127-36. doi: 10.1089/met.2009.0052. Metab Syndr Relat Disord. 2010. PMID: 20156067 Free PMC article. Clinical Trial.
Lack of effect of short-term diazoxide administration on luteinizing hormone secretion in women with polycystic ovary syndrome.
Evans WS, Taylor AE, Boyd DG, Johnson ML, Matt DW, Jimenez Y, Nestler JE. Evans WS, et al. Fertil Steril. 2007 Jul;88(1):118-24. doi: 10.1016/j.fertnstert.2006.11.109. Epub 2007 Feb 6. Fertil Steril. 2007. PMID: 17289040